Tenax Therapeutics (TENX) |
|
1.38 -0.12 (-8%)
|
06-04 16:00 |
|
Open: |
1.47 |
Pre. Close: |
1.5 |
|
High:
|
1.54 |
Low:
|
1.33 |
|
Volume:
|
1,264,509 |
Market Cap:
|
13M |
|
|
|
|
Tenax Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing & commercializing pharmaceutical products for critical care patients and its products include Levosimendan & Oxycyte. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.541 - 1.551 |
1.551 - 1.56 |
|
Low:
|
1.312 - 1.321 |
1.321 - 1.329 |
|
Close:
|
1.367 - 1.381 |
1.381 - 1.394 |
|
Technical analysis |
as of: 2020-06-04 4:36:25 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 2.20 One year: 3.13 |
| Support: |
Support1: 0.60 Support2: 0.50 |
| Resistance: |
Resistance1: 1.89 Resistance2: 2.68 |
| Pivot: |
1.26  |
| Moving Average: |
MA(5): 1.48 MA(20): 1.12
MA(100): 0.96 MA(250): 1.15 |
| MACD: |
MACD(12,26): 0.21 Signal(9): 0.18 |
| Stochastic oscillator: |
%K(14,3): 41.39 %D(3): 52.63 |
| RSI: |
RSI(14): 63.98 |
| 52-week: |
High: 2.68 Low: 0.25 Change(%): 8.7 |
| Average Vol(K): |
3-Month: 131558 10-Days: 635064 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.TENX has closed below upper band by 37.2%. Bollinger Bands are 130.6% wider than normal. The large width of the bands suggest high volatility as compared to TENX's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 02 Jun 2020
Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - Business Wire
Thu, 04 Jun 2020
Tenax Therapeutics Inc. [TENX] moved down -8.54: Why It’s Important - The DBT News
Wed, 03 Jun 2020
Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
Wed, 03 Jun 2020
Tenax Therapeutics (TENX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - StreetInsider.com
Tue, 02 Jun 2020
Thinking about buying stock in Tenax Therapeutics, Allena Pharmaceuticals, Trevena, Adaptimmune Therapeutics, or Aurora Cannabis? - PRNewswire
Fri, 29 May 2020
Tenax Therapeutics Inc. [TENX] Stock trading around $1.50 per share: What’s Next? - The DBT News
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
9 |
| Shares Float (M) |
8 |
|
% Held by Insiders
|
0.39 |
|
% Held by Institutions
|
21.77 |
|
Shares Short (K)
|
74 |
|
Shares Short P. Month (K)
|
62 |
Stock Financials |
|
EPS
|
-1.404 |
|
EPS Est This Year
|
-0.360 |
|
EPS Est Next Year
|
-0.280 |
|
Book Value (p.s.)
|
0.430 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-68.6 |
|
Return on Equity (ttm)
|
-137.1 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.036 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-8 |
|
Levered Free Cash Flow (M)
|
-5 |
Stock Valuations |
|
PE Ratio
|
-0.98 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.21 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-1.57 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
